| Sarah Maxine White, DO | |
|
1263 State Route 40 West, Po Box N, Claysville, PA 15323-0513 | |
| (724) 663-7731 | |
| (724) 663-9022 |
| Full Name | Sarah Maxine White |
|---|---|
| Gender | Female |
| Speciality | Family Practice |
| Experience | 11 Years |
| Location | 1263 State Route 40 West, Claysville, Pennsylvania |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1225474315 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Q00000X | Family Medicine | OS017318 (Pennsylvania) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Amedisys Home Health Of Pa | Uniontown, PA | Home health agency |
| Gallagher Home Health Services | Bridgeville, PA | Home health agency |
| Gateway Hospice | Pittsburgh, PA | Hospice |
| Washington Hospital, The | Washington, PA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Claysville Family Practice Inc | 2961308507 | 7 |
News Archive
A phase I clinical trial enrolled its first patient only two days after U.S. Food and Drug Administration clearance of the experimental drug for a first-in-human cancer trial, a milestone that normally takes three to six months. Investigators from The University of Texas M. D. Anderson Cancer Center and pharmaceutical company AstraZeneca have reported their work in the Journal of Clinical Oncology published online on August 3rd.
XIFIN Inc., the leading provider of revenue cycle management for diagnostic service providers, today announced that the company has been named to the 2010 Inc. 5000 list of fastest-growing private companies for the fourth consecutive year, ranking 1,447th. The company ranked No. 96 in Top Software Companies, and No. 34 in Top Companies in the San Diego Metro Area. The list is widely regarded to include the most innovative and entrepreneurial companies in the nation.
In a remarkable new advance against the virus that causes AIDS, scientists from the Jupiter, Florida campus of The Scripps Research Institute have announced the creation of a novel drug candidate that is so potent and universally effective, it might work as part of an unconventional vaccine.
An international team of genetics researchers has discovered four new gene regions that contribute to low birth weight. Three of those regions influence adult metabolism, and appear to affect longer-term outcomes such as adult height, risk of type 2 diabetes and adult blood pressure.
The five-year survival rate for people on dialysis is under 50 percent. University of California researchers are hoping to improve that prognosis.
› Verified 6 days ago
| Entity Name | Claysville Family Practice Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1184675035 PECOS PAC ID: 2961308507 Enrollment ID: O20031212000279 |
News Archive
A phase I clinical trial enrolled its first patient only two days after U.S. Food and Drug Administration clearance of the experimental drug for a first-in-human cancer trial, a milestone that normally takes three to six months. Investigators from The University of Texas M. D. Anderson Cancer Center and pharmaceutical company AstraZeneca have reported their work in the Journal of Clinical Oncology published online on August 3rd.
XIFIN Inc., the leading provider of revenue cycle management for diagnostic service providers, today announced that the company has been named to the 2010 Inc. 5000 list of fastest-growing private companies for the fourth consecutive year, ranking 1,447th. The company ranked No. 96 in Top Software Companies, and No. 34 in Top Companies in the San Diego Metro Area. The list is widely regarded to include the most innovative and entrepreneurial companies in the nation.
In a remarkable new advance against the virus that causes AIDS, scientists from the Jupiter, Florida campus of The Scripps Research Institute have announced the creation of a novel drug candidate that is so potent and universally effective, it might work as part of an unconventional vaccine.
An international team of genetics researchers has discovered four new gene regions that contribute to low birth weight. Three of those regions influence adult metabolism, and appear to affect longer-term outcomes such as adult height, risk of type 2 diabetes and adult blood pressure.
The five-year survival rate for people on dialysis is under 50 percent. University of California researchers are hoping to improve that prognosis.
› Verified 6 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Sarah Maxine White, DO 1263 State Route 40 West, Po Box N, Claysville, PA 15323-0513 Ph: (724) 663-7731 | Sarah Maxine White, DO 1263 State Route 40 West, Po Box N, Claysville, PA 15323-0513 Ph: (724) 663-7731 |
News Archive
A phase I clinical trial enrolled its first patient only two days after U.S. Food and Drug Administration clearance of the experimental drug for a first-in-human cancer trial, a milestone that normally takes three to six months. Investigators from The University of Texas M. D. Anderson Cancer Center and pharmaceutical company AstraZeneca have reported their work in the Journal of Clinical Oncology published online on August 3rd.
XIFIN Inc., the leading provider of revenue cycle management for diagnostic service providers, today announced that the company has been named to the 2010 Inc. 5000 list of fastest-growing private companies for the fourth consecutive year, ranking 1,447th. The company ranked No. 96 in Top Software Companies, and No. 34 in Top Companies in the San Diego Metro Area. The list is widely regarded to include the most innovative and entrepreneurial companies in the nation.
In a remarkable new advance against the virus that causes AIDS, scientists from the Jupiter, Florida campus of The Scripps Research Institute have announced the creation of a novel drug candidate that is so potent and universally effective, it might work as part of an unconventional vaccine.
An international team of genetics researchers has discovered four new gene regions that contribute to low birth weight. Three of those regions influence adult metabolism, and appear to affect longer-term outcomes such as adult height, risk of type 2 diabetes and adult blood pressure.
The five-year survival rate for people on dialysis is under 50 percent. University of California researchers are hoping to improve that prognosis.
› Verified 6 days ago
Dr. Abigail Templeton, M.D. Family Medicine Medicare: Medicare Enrolled Practice Location: 1263 State Route 40 West, Po Box N, Claysville, PA 15323 Phone: 724-663-7731 Fax: 724-663-9022 | |
Dr. Mark Allen Mamros, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 1263 Route 40 W, Claysville, PA 15323 Phone: 724-663-7731 Fax: 724-663-9022 | |
Jay M Ziegler, M.D. Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 1263 Route 40 W, Claysville, PA 15323 Phone: 724-663-9018 Fax: 724-663-9022 | |
Frederick J Landenwitsch, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 1263 Route 40 W, Claysville, PA 15323 Phone: 724-663-9018 Fax: 724-663-9022 | |
Kristen S Romesburg, DO Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 1263 State Route 40 W, Po Box N, Claysville, PA 15323 Phone: 724-663-7731 Fax: 724-663-9022 | |
John David Six, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 1263 Route 40 W, Claysville, PA 15323 Phone: 724-663-9018 Fax: 724-663-9022 |